Literature DB >> 18339791

Pleural fluid analysis in chylous pleural effusion.

Vishal Agrawal1, Peter Doelken2, Steven A Sahn2.   

Abstract

OBJECTIVES: Chyle is a noninflammatory, lymphocyte-predominant fluid that may cause a pleural effusion as a consequence of thoracic duct leakage into the pleural space. Although chyle is reported to have protein concentrations in the transudative range, chylous effusions are typically exudative, as defined by the standard criteria. We hypothesized that chylous effusions from a thoracic duct leak alone have low lactate dehydrogenase (LDH) concentrations due to the absence of inflammation and are lymphocyte-predominant, protein-discordant exudates. Consequently, pleural effusions that do not meet these criteria but with triglyceride concentrations of > 110 mg/dL or are positive for chylomicrons should be associated with other diagnoses contributing to pleural fluid formation. STUDY
DESIGN: Retrospective.
METHODS: The pleural fluid analyses of 876 consecutive thoracenteses were reviewed. All cases with a triglyceride concentration of > 110 mg/dL or the presence of chylomicrons were retrieved. The effusions were then classified as transudates, concordant exudates, protein-discordant exudates, and LDH-discordant exudates, and according to lymphocyte predominance (> 50%). The causes of these pleural effusions were determined after the review of the medical record.
RESULTS: Twenty-two pleural effusions had elevated triglyceride concentrations and/or were positive for chylomicrons. Eleven effusions were lymphocyte-predominant, protein-discordant exudates, and two of these were associated with chylous ascites. The remaining effusions were transudates (n = 7) or concordant exudates (n = 4); all were associated with conditions known to cause pleural effusion apart from chyle leakage.
CONCLUSION: Chylous effusions caused solely by conditions known to cause chylothorax were lymphocyte-predominant, protein-discordant exudates. Protein concentrations in the transudative range or elevated LDH concentrations were associated with a coexisting condition that may impact the management of these chylous effusions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339791     DOI: 10.1378/chest.07-2232

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

Review 1.  Chyle leak following laparoscopic cholecystectomy: a rare complication.

Authors:  Petrut Gogalniceanu; Sanjay Purkayastha; Duncan Spalding; Emmanouil Zacharakis
Journal:  Ann R Coll Surg Engl       Date:  2010-08-09       Impact factor: 1.891

2.  Urinothorax: a systematic review.

Authors:  María E Toubes; Adriana Lama; Lucía Ferreiro; Antonio Golpe; José M Álvarez-Dobaño; Francisco J González-Barcala; Esther San José; Nuria Rodríguez-Núñez; Carlos Rábade; Tamara Lourido; Luis Valdés
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 3.  Bilateral chylothorax: an unusual complication of cervical rib resection.

Authors:  Jaymin B Morjaria; Imran Aslam; Brian Johnson; Michael A Greenstone; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2015-01       Impact factor: 5.091

4.  Postoperative chylothorax successfully treated using conservative strategies.

Authors:  Victoria Stager; Lam Le; Richard E Wood
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

5.  Dasatinib-induced chylothorax in chronic myeloid leukemia.

Authors:  Zulfiqar Qutrio Baloch; Shabber Agha Abbas; Hammad Bhatti; Yvonne Braver; Sayed K Ali
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-01

6.  Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy.

Authors:  Or Kalchiem-Dekel; Christina J Falcon; Christine M Bestvina; Dazhi Liu; Lauren A Kaplanis; Clare Wilhelm; Jordan Eichholz; Guilherme Harada; Lori J Wirth; Subba R Digumarthy; Robert P Lee; David Kadosh; Robin B Mendelsohn; Jessica Donington; Justin F Gainor; Alexander Drilon; Jessica J Lin
Journal:  J Thorac Oncol       Date:  2022-07-02       Impact factor: 20.121

7.  Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature review.

Authors:  Theresa Paul; Anil Yousaf Ellahie; Yazan Salah Almohtasib; Urshita Sinha; Halima El Omri
Journal:  EJHaem       Date:  2021-05-18

8.  Pleural fluid characteristics of chylothorax.

Authors:  Fabien Maldonado; Finn J Hawkins; Craig E Daniels; Clinton H Doerr; Paul A Decker; Jay H Ryu
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 9.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

10.  Chylous ascites and pleural transudate: rare presentations in systemic lupus erythematosus in old age.

Authors:  Guan-Liang Chen; Deng-Ho Yang; Wen-Hsiu Hsu
Journal:  Case Reports Immunol       Date:  2012-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.